Viatris Inc at JPMorgan Healthcare Conference Transcript
Good morning. I'm Chris Schott at JPMorgan, and it's my pleasure to be hosting this fireside discussion this morning with Viatris. We're going to have a quick presentation from CEO, Scott Smith, and they're going to open up to a Q&A session with the broader management team as well.
So with that, I'll turn it over to Scott.
Thank you, Chris, and thank you, everybody who has attended us today. Very nice for you to come. Just let me click this over. Forward-looking statement to put on here for a second. We're going to be talking about forward-looking things.
So just before we get started, I'd like to just give a little snapshot about Viatris and who we are as a company. We're not one business. We're actually three separate businesses, as a global generics company, an established brands company that owns some of the most iconic brands in the world that you can see up there, and an emerging innovative brands platform. Over the
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |

